NOVARTIS logo.jpg
Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19
28 oct. 2020 02h15 HE | Novartis International AG
Novartis has been granted an option to in-license global rights of MP0420 and MP0423 - multi-targeted direct acting antiviral therapeutic candidates demonstrating potential efficacy against...
22157.jpg
Global Pharma and Biotech Preclinical Stage Partnering Deals, Terms and Agreements Report 2014-2020
16 sept. 2020 05h43 HE | Research and Markets
Dublin, Sept. 16, 2020 (GLOBE NEWSWIRE) -- The "Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2020" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global Biotech Partnering Deals, Terms and Agreements Report 2016-2020
14 sept. 2020 07h28 HE | Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Global Biotech Partnering Terms and Agreements 2016-2020" report has been added to ResearchAndMarkets.com's offering. Global Biotech Partnering...
Cytovia.png
Cytovia Therapeutics Licenses Productivity-Boosting Manufacturing Technology for Its NK Engager Multifunctional Antibodies From ProteoNic
12 août 2020 09h04 HE | Cytovia Therapeutics
NEW YORK and LEIDEN, the Netherlands, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc (Cytovia), an emerging biopharmaceutical company developing CAR NK cell therapy and NK engager...
University of Oregon Department of Human Physiology Approved for Funding from ARCS® Foundation
19 mai 2020 15h28 HE | ARCS Foundation Inc.
LaGrange, GA, May 19, 2020 (GLOBE NEWSWIRE) -- ARCS® Foundation is pleased to announce the addition of University of Oregon’s Department of Human Physiology to its approved departments for funding. ...
University of Minnesota Department of Neuroscience Approved for Funding from ARCS Foundation
15 avr. 2020 11h09 HE | ARCS Foundation Inc.
LaGrange, GA, April 15, 2020 (GLOBE NEWSWIRE) -- ARCS® Foundation is pleased to announce it has approved adding the Department of Neuroscience within the University of Minnesota Medical School to...
Cytovia.png
CYTOVIA Therapeutics and the New York Stem Cell Foundation Research Institute enter into a partnership to develop iPSC derived CAR NK Therapeutics
09 janv. 2020 08h00 HE | Cytovia Therapeutics
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The New York Stem Cell Foundation (NYSCF) Research Institute today announced a partnership with Cytovia Therapeutics Inc. (Cytovia) to develop new disease...
Cytovia Therapeutics and the University of California, San Francisco enter into a partnership to develop precision gene-edited CAR-NK cell therapy
06 janv. 2020 08h00 HE | Cytovia Therapeutics
SAN FRANCISCO and NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, a biopharmaceutical company, and the University of California, San Francisco (UCSF) announced today that they have...
energias.jpg
Global Regenerative Medicine Market to Witness a CAGR of 20.5% during 2018-2024
18 mars 2019 10h37 HE | Energias Market Research
NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Global regenerative medicine market is expected to reach USD 79.8 billion by 2024, at a CAGR of 20.5% from 2018 to 2024. Factors driving the growth of...
FLYWHEEL LOGO.png
Flywheel Partners with Google Cloud to Provide Clinical Researchers with Advanced Cloud Technology and Machine Learning for Medical Imaging
11 févr. 2019 07h00 HE | Flywheel
MINNEAPOLIS and MOUNTAIN VIEW, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Flywheel, provider of cloud-based collaborative science solutions for biomedical research, today announced a technology...